Jing Zhu

Company: ReciBioPharm

Job title: Vice President, Head of Process Development

Seminars:

An mRNA Knowledge Library: Deep Profiling of Wild Type & Modified T7 Polymerases & Their Impacts on IVT Performance 9:00 am

A high throughput screening (HTS) workflow was developed to enable comprehensive evaluation of T7 polymerase as a critical raw material in mRNA production Total 4 of wild type and 16 of modified T7 polymerases were systematically evaluated via DOE based IVT optimizations and subsequently mRNA analytics  A ranking system including mRNA production performance, supply chain,…Read more

day: Day 2 AM